161 related articles for article (PubMed ID: 36030300)
21. Comprehensive metabolic profiling of Parkinson's disease by liquid chromatography-mass spectrometry.
Shao Y; Li T; Liu Z; Wang X; Xu X; Li S; Xu G; Le W
Mol Neurodegener; 2021 Jan; 16(1):4. PubMed ID: 33485385
[TBL] [Abstract][Full Text] [Related]
22. A metabolomic study for chronic heart failure patients based on a dried blood spot mass spectrometry approach.
Zhao G; Cheng D; Wang Y; Cao Y; Xiang S; Yu Q
RSC Adv; 2020 May; 10(33):19621-19628. PubMed ID: 35515477
[No Abstract] [Full Text] [Related]
23. A Simultaneous Metabolic Profiling and Quantitative Multimetabolite Metabolomic Method for Human Plasma Using Gas-Chromatography Tandem Mass Spectrometry.
Savolainen OI; Sandberg AS; Ross AB
J Proteome Res; 2016 Jan; 15(1):259-65. PubMed ID: 26615962
[TBL] [Abstract][Full Text] [Related]
24. Combined application of NMR- and GC-MS-based metabonomics yields a superior urinary biomarker panel for bipolar disorder.
Chen JJ; Liu Z; Fan SH; Yang DY; Zheng P; Shao WH; Qi ZG; Xu XJ; Li Q; Mu J; Yang YT; Xie P
Sci Rep; 2014 Jul; 4():5855. PubMed ID: 25068480
[TBL] [Abstract][Full Text] [Related]
25. Noninvasive diagnosis and evaluation of curative surgery for gastric cancer by using NMR-based metabolomic profiling.
Jung J; Jung Y; Bang EJ; Cho SI; Jang YJ; Kwak JM; Ryu DH; Park S; Hwang GS
Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S736-42. PubMed ID: 25092158
[TBL] [Abstract][Full Text] [Related]
26. Profiling of urinary amino-carboxylic metabolites by in-situ heptafluorobutyl chloroformate mediated sample preparation and gas chromatography-mass spectrometry.
Hušek P; Švagera Z; Hanzlíková D; Řimnáčová L; Zahradníčková H; Opekarová I; Šimek P
J Chromatogr A; 2016 Apr; 1443():211-32. PubMed ID: 27012787
[TBL] [Abstract][Full Text] [Related]
27. High serum levels of L-carnitine and citric acid negatively correlated with alkaline phosphatase are detectable in Koreans before gastric cancer onset.
Han Y; Yoo HJ; Jee SH; Lee JH
Metabolomics; 2022 Jul; 18(8):62. PubMed ID: 35900644
[TBL] [Abstract][Full Text] [Related]
28. Plasma sample based analysis of gastric cancer progression using targeted metabolomics.
Lario S; Ramírez-Lázaro MJ; Sanjuan-Herráez D; Brunet-Vega A; Pericay C; Gombau L; Junquera F; Quintás G; Calvet X
Sci Rep; 2017 Dec; 7(1):17774. PubMed ID: 29259332
[TBL] [Abstract][Full Text] [Related]
29. Tissue metabolomic fingerprinting reveals metabolic disorders associated with human gastric cancer morbidity.
Song H; Wang L; Liu HL; Wu XB; Wang HS; Liu ZH; Li Y; Diao DC; Chen HL; Peng JS
Oncol Rep; 2011 Aug; 26(2):431-8. PubMed ID: 21567103
[TBL] [Abstract][Full Text] [Related]
30. Metabolic Profiling of Urinary Chiral Amino-Containing Biomarkers for Gastric Cancer Using a Sensitive Chiral Chlorine-Labeled Probe by HPLC-MS/MS.
Huang R; Shen K; He Q; Hu Y; Sun C; Guo C; Pan Y
J Proteome Res; 2021 Aug; 20(8):3952-3962. PubMed ID: 34229439
[TBL] [Abstract][Full Text] [Related]
31. Application of global metabolomic profiling of synovial fluid for osteoarthritis biomarkers.
Carlson AK; Rawle RA; Adams E; Greenwood MC; Bothner B; June RK
Biochem Biophys Res Commun; 2018 May; 499(2):182-188. PubMed ID: 29551687
[TBL] [Abstract][Full Text] [Related]
32. Serum metabolic profiling of human gastric cancer based on gas chromatography/mass spectrometry.
Song H; Peng JS; Dong-Sheng Y; Yang ZL; Liu HL; Zeng YK; Shi XP; Lu BY
Braz J Med Biol Res; 2012 Jan; 45(1):78-85. PubMed ID: 22124703
[TBL] [Abstract][Full Text] [Related]
33. Comprehensive urinary metabolomic profiling and identification of potential noninvasive marker for idiopathic Parkinson's disease.
Luan H; Liu LF; Tang Z; Zhang M; Chua KK; Song JX; Mok VC; Li M; Cai Z
Sci Rep; 2015 Sep; 5():13888. PubMed ID: 26365159
[TBL] [Abstract][Full Text] [Related]
34. Tandem mass spectrometry-based newborn screening strategy could be used to facilitate rapid and sensitive lung cancer diagnosis.
Huang T; Cao Y; Zeng J; Dong J; Sun X; Chen J; Gao P
Onco Targets Ther; 2016; 9():2479-87. PubMed ID: 27217771
[TBL] [Abstract][Full Text] [Related]
35. Metabolomics study identified bile acids as potential biomarkers for gastric cancer: A case control study.
Pan C; Deng D; Wei T; Wu Z; Zhang B; Yuan Q; Liang G; Liu Y; Yin P
Front Endocrinol (Lausanne); 2022; 13():1039786. PubMed ID: 36465663
[TBL] [Abstract][Full Text] [Related]
36. Tissue-based metabolomics reveals metabolic signatures and major metabolic pathways of gastric cancer with help of transcriptomic data from TCGA.
Wang Y; Chen W; Li K; Wu G; Zhang W; Ma P; Feng S
Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34549263
[TBL] [Abstract][Full Text] [Related]
37. Divergent Urinary Metabolic Phenotypes between Major Depressive Disorder and Bipolar Disorder Identified by a Combined GC-MS and NMR Spectroscopic Metabonomic Approach.
Chen JJ; Zhou CJ; Liu Z; Fu YY; Zheng P; Yang DY; Li Q; Mu J; Wei YD; Zhou JJ; Huang H; Xie P
J Proteome Res; 2015 Aug; 14(8):3382-9. PubMed ID: 26168936
[TBL] [Abstract][Full Text] [Related]
38. Integrated metabolomic profiling of hepatocellular carcinoma in hepatitis C cirrhosis through GC/MS and UPLC/MS-MS.
Fitian AI; Nelson DR; Liu C; Xu Y; Ararat M; Cabrera R
Liver Int; 2014 Oct; 34(9):1428-44. PubMed ID: 24661807
[TBL] [Abstract][Full Text] [Related]
39. Discovery and validation of potential urinary biomarkers for bladder cancer diagnosis using a pseudotargeted GC-MS metabolomics method.
Zhou Y; Song R; Ma C; Zhou L; Liu X; Yin P; Zhang Z; Sun Y; Xu C; Lu X; Xu G
Oncotarget; 2017 Mar; 8(13):20719-20728. PubMed ID: 28157703
[TBL] [Abstract][Full Text] [Related]
40. Metabolic Pathway Extension Approach for Metabolomic Biomarker Identification.
Wang L; Ye H; Sun D; Meng T; Cao L; Wu M; Zhao M; Wang Y; Chen B; Xu X; Wang G; Hao H
Anal Chem; 2017 Jan; 89(2):1229-1237. PubMed ID: 27983783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
